Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LAURION Intercepts of 37.70 g/t Gold over 0.50 m, 6.60 g/t Gold over 1.00 m (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
BioVaxys Technology Corp.
C.BIOV
Alternate Symbol(s):
BVAXF
Healthcare
Biotechnology
BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving patient lives with novel immunotherapies based on the DPX immune-educating technology platform and its HapTenix neoantigen tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization and other immunological fields. The Company's clinical...
-stage pipeline includes maveropepimut-S, which is in phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using its HapTenix neoantigen tumor cell construct platform for treating refractive late-stage ovarian cancer. The Company is also leveraging its expertise in tumor immunology by creating a unique library of T-lymphocytes and other datasets post-vaccination with its personalized immunotherapeutic vaccines to identify new targetable tumor antigens.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Company Website
Add To Watchlist
Bullboard (CSE:BIOV)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Mar 05, 2024 8:00am
New Press Release - BioVaxys Announces Allowance of DPX-Related Patent for Japan and Filing of Additional International Patent Applications
VANCOUVER, BC, March 5, 2024 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") announced that it has received a Notice of Allowance from the Japanese Patent Office for a Patent ("Patent") for inducing an antibody immune response from a low...
read article.
(76)
•••
Humanist
X
View Profile
View Bullboard History
Post by
Humanist
on Mar 04, 2024 11:19am
what a dichotomy in Biov's trading volume.
We're either to the moon or nothing... :) it would be nice to see continuous attention and stabilitity/consistency ...
(5)
•••
NewMexicats
X
View Profile
View Bullboard History
Post by
NewMexicats
on Feb 29, 2024 4:33pm
BioVaxys Article
https://www.medicalgold.ca/posts/biovaxys-bargain-bonanza-seizing-a-biotech-treasure-trove-from-imvs-ashes
(0)
•••
MtnClimber
X
View Profile
View Bullboard History
Post by
MtnClimber
on Feb 28, 2024 3:02pm
So much potential
I see so much potential for BIOV. Their newly acquired IP portfolio has so many applications. They are setting the stage for an acquisition.
(298)
•••
moneywagon
X
View Profile
View Bullboard History
Post by
moneywagon
on Feb 26, 2024 12:53pm
BIOV THIS IS PROFIT TAKING ZONE FOR SOME~ME FEET UP
I waited long enuf for this train to move so I'm not going ANYWHERE plus it was a super great opportunity down in the dips. Hang 6 Humanist, :>)) shout out LONG$$$$$S
(76)
•••
Humanist
X
View Profile
View Bullboard History
Post by
Humanist
on Feb 26, 2024 9:53am
anyone is surprised with stock price rising tdy on good vol?
I am! I thought it would take a breather until the finacial are filed etc.. unless there is more news and someone is in the know! just htinking outloud.. thoughts!!
(5)
•••
NewMexicats
X
View Profile
View Bullboard History
Comment by
NewMexicats
on Feb 23, 2024 3:19pm
RE:They did for years in O&G industry
They have said they will focus on licensing the DPX Platform. My hope is this attracts a buy out, although the licensing could be lucrative.
(13)
•••
Magnum2
X
View Profile
View Bullboard History
Post by
Magnum2
on Feb 23, 2024 1:41pm
They did for years in O&G industry
Company A would buy out Company B that had huge losses on their books so as to minimize or eliminate taxes on future earnings. Ended up with shares in BIOV after the Mining Co. became pharma, bought
...more
(5)
•••
NewMexicats
X
View Profile
View Bullboard History
Comment by
NewMexicats
on Feb 23, 2024 1:37am
RE:Looks as though they bought the losses
Losses? Bought only intellectual property on a sweet deal. No debt. What did I miss? Revenue from licensing DPX Platform & Biovaxys Platform. Personally hoping big
...more
(13)
•••
Magnum2
X
View Profile
View Bullboard History
Post by
Magnum2
on Feb 23, 2024 1:09am
Looks as though they bought the losses
now they just need some revenue. Still too early, probably sells off yet again, I wouldn't chase it. GLTA
(76)
•••
Humanist
X
View Profile
View Bullboard History
Comment by
Humanist
on Feb 22, 2024 6:03pm
RE:Newsletter released by Biov
WOW A LOT TO UNPACK IN HERE, MUST READ.. good find Mario as for the delay in filing, although it's required by feb 28 , the letter indicated they may not make it which may push it to on or
...more
(195)
•••
Mario79
X
View Profile
View Bullboard History
Post by
Mario79
on Feb 22, 2024 4:51pm
Newsletter released by Biov
Newletter released by BIOV about 30 minutes before close that saw huge volume. Here is the newsletter: News & Updates February 2024 We did it!! It’s an understatement to say that BioVaxys is
...more
(79)
•••
WinterBaron
X
View Profile
View Bullboard History
Comment by
WinterBaron
on Feb 22, 2024 2:20pm
RE:i hope sellers are not selling becasue of the filing delay!
Most likely the reason.
(5)
•••
NewMexicats
X
View Profile
View Bullboard History
Comment by
NewMexicats
on Feb 22, 2024 1:34pm
RE:i hope sellers are not selling becasue of the filing delay!
This quote from Ken Kovan, COO, has got me thinking about how many big PRs we've got coming our way driving attention to the stock "Over the upcoming months our plan is to drive more organic
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Do you want to stay ahead of the markets? See how DealRoom can help.
Why Dozens of Pro Athletes are Paying Attention to this Product
Q Precious & Battery Metals To Resume Diamond Drilling La Corne South Project, Val D'or Quebec
Webinar Dec. 12, 2024: Transforming Regenerative Medicine. Register Now